Aixtron’s High-Wire Act: A €359 Million Backlog Meets Market Skepticism Ahead of July 30

The German semiconductor equipment maker Aixtron presents an increasingly contradictory picture. Its order book has swelled to record levels, two Wall Street heavyweights have been buying shares aggressively, and yet the stock has shed nearly a third of its value from a June high — landing at €43.90 on Friday after a 2.79% daily drop. The tension between these signals will come to a head on July 30, when the company publishes its half-year results and must show whether a mountain of orders can finally translate into tangible revenue.

Digging into the first-quarter numbers reveals the core of the puzzle. Aixtron booked €171.4 million in new orders in the period, a 30% year-on-year surge, while revenue plunged to just €59.4 million from €112.5 million a year earlier. The resulting order backlog climbed to €359.1 million — a record that management expects to convert into second-quarter sales of roughly €110 million, give or take €10 million. The critical question hanging over the July report is whether that conversion is proceeding at a pace that can also rebuild margins.

The bull case rests on a clear driver: optoelectronics, which accounted for nearly 70% of first-quarter order intake. Laser chips for optical data links in AI data centers are fueling demand, and Aixtron — as a leading supplier of MOCVD deposition equipment — holds a structural position in that build-out. Management has already raised its 2026 full-year guidance, targeting revenue of €530 million to €590 million and an EBIT margin between 17% and 20%. The company’s balance sheet adds a further buffer: a net cash position with zero debt gives Aixtron the financial room to weather the current revenue trough without refinancing pressure.

Yet the bearish arguments are equally prominent. Weakness in the silicon carbide power electronics market, plagued by massive overcapacity, weighed on the first quarter. GaN tools stabilized only at low levels. The operating result came in at minus €22.3 million, partly due to one-time personnel costs and lower volumes, while the gross margin compressed to 18%. On valuation, the stock trades at a forward price-to-earnings ratio of 67.4 for 2026 — roughly 67% above the median of its peer group, which includes Veeco, Besi, ASM International, Süss MicroTec, Jenoptik and Camtek. That premium leaves little room for disappointment, and the broader semiconductor sector has been in a sustained sell-off that has also hit names like ASML and Infineon.

Should investors sell immediately? Or is it worth buying Aixtron?

Against that backdrop, the recent moves by UBS and Goldman Sachs stand out as contrarian bets. UBS now holds around 4% of Aixtron shares, while Goldman Sachs has built a position exceeding 8.6%. Their accumulation occurred during the steepest part of the decline — the stock has dropped 17.57% over the past month and 10.84% in the last week alone. No specific negative company news triggered the slide; rather, a Bank of America analyst preview on expected second-quarter order intake added to nervousness ahead of the official numbers.

From a technical perspective, the shares are testing a critical level. At €43.90, the stock sits just above its 100-day moving average of €43.70, well below the 50-day line at €52.96. The relative strength index of 37.9 points to oversold conditions. A break below the 100-day mark would darken the technical outlook, while a move back above the 50-day average would confirm a recovery attempt.

Most analyst houses currently rate the stock neutral, with a consensus target near the prevailing price. The annualized 30-day volatility of 83.70% underscores how high the stakes have become for a company whose fundamental narrative splits neatly into two opposing camps: a long-term AI infrastructure beneficiary with a fortress balance sheet, versus a cyclical semiconductor play facing sector headwinds, a demanding valuation, and the unresolved question of whether its backlog will actually convert into profitable revenue. The July 30 half-year report is the moment when those two views will begin to find an answer.